Microphysiometry: new technology for evaluation of anticancer drug activity in human tumor cells in vitro

被引:23
作者
Ekelund, S [1 ]
Nygren, P
Larsson, R
机构
[1] Univ Uppsala, Akad Hosp, Div Clin Pharmacol, S-75185 Uppsala, Sweden
[2] Univ Uppsala, Akad Hosp, Dept Oncol, S-75185 Uppsala, Sweden
关键词
cell metabolism; cytotoxic drugs; cytosensor; microphysiometry;
D O I
10.1097/00001813-199807000-00003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microphysiometry is a non-invasive, physiological method where measurement of metabolic activity can be made on living human tumor cells. Indirect measurement of the extracellular acidification is measured over a pH-sensitive silicon membrane. In this study microphysiometry was employed for the study of cytotoxic agents used in therapy of cancer. Standard cytotoxic drugs with different postulated mechanisms of action were investigated using cell lines as well as primary cultures of patient tumor cells. Each investigated cytotoxic drug induced a characteristic pattern of metabolic activity. From these patterns, key features, like stimulation and inhibition of acidification, the time point when the response curves of the drugs fall below the control curve, and the maximum inhibition of acidification at 20 h, could be quantified. Most of the investigated drugs showed some initial stimulation of acidification rate during the experiments. For drugs producing a reduced metabolic rate at 20 h a concentration-response relationship was observed. The drug effects measured at 20 h were irreversible and correlated reasonably well with parallel measurements of membrane integrity using a standard cytotoxicity test. The results demonstrate the feasibility of 'on-line' measurements of metabolic activity using this approach and also revealed an unexpected variety of drug response profiles. [(C) 1998 Lippincott-Raven Publishers.].
引用
收藏
页码:531 / 538
页数:8
相关论文
共 20 条
[1]   USING MICROPHYSIOMETRY TO STUDY THE PHARMACOLOGY OF EXOGENOUSLY EXPRESSED M(1) AND M(3) MUSCARINIC RECEPTORS [J].
BAXTER, GT ;
YOUNG, ML ;
MILLER, DL ;
OWICKI, JC .
LIFE SCIENCES, 1994, 55 (08) :573-583
[2]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[3]  
CHIO CL, 1994, J BIOL CHEM, V269, P11813
[4]   VIABILITY MEASUREMENTS IN MAMMALIAN-CELL SYSTEMS [J].
COOK, JA ;
MITCHELL, JB .
ANALYTICAL BIOCHEMISTRY, 1989, 179 (01) :1-7
[5]   CYTOTOXIC DRUG-SENSITIVITY TESTING OF TUMOR-CELLS FROM PATIENTS WITH OVARIAN-CARCINOMA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA) [J].
CSOKA, K ;
LARSSON, R ;
THOLANDER, B ;
GERDIN, E ;
DELATORRE, M ;
NYGREN, P .
GYNECOLOGIC ONCOLOGY, 1994, 54 (02) :163-170
[6]   Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance [J].
Dhar, S ;
Nygren, P ;
Csoka, K ;
Botling, J ;
Nilsson, K ;
Larsson, R .
BRITISH JOURNAL OF CANCER, 1996, 74 (06) :888-896
[7]  
FRUEHAUF JP, 1993, PRINCIPLES PRACTICE, V7, P1
[8]   LIGHT-ADDRESSABLE POTENTIOMETRIC SENSOR FOR BIOCHEMICAL SYSTEMS [J].
HAFEMAN, DG ;
PARCE, JW ;
MCCONNELL, HM .
SCIENCE, 1988, 240 (4856) :1182-1185
[9]   LABORATORY DETERMINATION OF CHEMOTHERAPEUTIC DRUG-RESISTANCE IN TUMOR-CELLS FROM PATIENTS WITH LEUKEMIA, USING A FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA) [J].
LARSSON, R ;
KRISTENSEN, J ;
SANDBERG, C ;
NYGREN, P .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (02) :177-185
[10]   THE CYTOSENSOR MICROPHYSIOMETER - BIOLOGICAL APPLICATIONS OF SILICON TECHNOLOGY [J].
MCCONNELL, HM ;
OWICKI, JC ;
PARCE, JW ;
MILLER, DL ;
BAXTER, GT ;
WADA, HG ;
PITCHFORD, S .
SCIENCE, 1992, 257 (5078) :1906-1912